CU IRB
  Home For Research Subjects About the HRPP / IRB Contact Us Submitting a Protocol Maintaining IRB Approval
 

Columbia University Human Research Protection Program

 
 

Columbia University IRB

Regulations
-

Federal

-

State Law

Ethical Principles
Policies & Guidance
-

Selected University Research Policies

-

Institutional Review Board (IRB)

-

General

-

International Standards

-

Related Information

Education & Training
-

Required Training:

-

Additional Training Opportunities:

Frequently Asked Questions
Related Links
- CUMC IRB (Medical Center Campus)
-

RASCAL

- Sponsored Projects Administration
-

AAHRPP

-

OHRP

- PRIM&R
 

 

seal

Have questions, suggestions, or concerns about research that involves human subjects? Use the IRB Staff Directory or

Office email address ("Ask the IRB" link) to contact us!

 

 

News & Announcements

 

Visit the Morningside IRB Office on Wednesday’s

from 1:00-3:00 without an appointment*

When: Any Wednesday

Where: Studebaker Building

615 West 131st Street, 3rd Floor

(Building entrance is on W. 132nd Street due to construction)

Time: 1:00 pm – 3:00 pm

 

*Alternatively an appointment may be scheduled

by calling 212-851-7040.

 

Current list of CUMC IT certified systems:

https://secure.cumc.columbia.edu/cumcit/secure/security/scp_systems.html

5/6/2013 July-December 2013 IRB Submission Deadline and IRB Meeting Dates released
3/18/2013

IRB 101: Human Subjects Research Protections & How to Submit a Protocol to the CU IRB-Morningside

Date: Wednesday, May 29, 2013

Time: 4:10-5:30

Location: Hamilton 503

 

More...

 

 

Policy & Guidance Refresher

 

May 2013

WITHDRAWAL OF SUBJECTS FROM FDA-REGULATED STUDIES

 

This guidance provides insights on how to best handle subjects who voluntarily drop-out from a clinical trial or are withdrawn from the study by the clinical investigator. It also helps to clarify FDA’s longstanding policy that data that has already been collected from subjects must be retained in the study data for the given clinical trial even if the subject voluntarily drops-out of the study. Based on the FDA’s October 2008 “Guidance for Sponsors, Clinical Investigators, and IRBs – Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials”, it provides additional guidance to the Columbia University “Informed Consent Policy”.

 

PGR Archive

 

Information for Research Subjects
  • Research at Columbia University
  • What is the IRB?
  • Should I Participate in Research?
About the HRPP / IRB
  • Purpose / Scope / Responsibilities
  • IRB Roster and Meeting Schedule
  • Quality Improvement Program
  • Compliance Oversight
  • Federalwide Assurance
Contact Us
 Submitting a Protocol
  • RASCAL Tutorial
  • Tips for Efficient Protocol Review
  • Resubmitting
  • Creating Consent Forms

Maintaining IRB Approval

  • Modifying a Protocol
  • Renewing a Protocol
  • Other Reporting Requirements

     -Adverse Events                                     

     -Protocol Deviations & Violations  
     -Interim Analysis / Safety Reports
     -Suspension

  • Closing out a Project
     
 

CUMC Home | At Columbia University | Affiliated with New York-Presbyterian Hospital | Comments | Text-Only Version